Similar articles

• Re: Liam Bourke, Stephen Gilbert, Richard Hooper, et al. Lifestyle changes for improving disease-specific quality of life in sedentary men on long-term androgen-deprivation therapy for advanced prostate cancer: a randomised controlled trial. Eur Urol 2014;65:865-72; Re: Daniel A. Galvão, Nigel Spry, James Denham, et al. A multicentre year-long randomised controlled trial of exercise training targeting physical functioning in men with prostate cancer previously treated with androgen suppression and radiation from TROG 03.04 RADAR. Eur Urol 2014;65:856-64; Re: Nancy L. Keating, Pang-Hsiang Liu, A. James O'Malley, Stephen J. Freedland, Matthew R. Smith. Androgen-deprivation therapy and diabetes control among diabetic men with prostate cancer. Eur Urol 2014;65:816-24; Re: Christina G. Jespersen, Mette Nørgaard, Michael Borre. Androgen-deprivation therapy in treatment of prostate cancer and risk of myocardial infarction and stroke: a nationwide Danish population-based cohort study. Eur Urol 2014;65:704-9.

  Goonewardene SS, Persad R, Young A, Makar A. Goonewardene SS, et al. Eur Urol. 2014 Sep;66(3):e51-2. doi: 10.1016/j.eururo.2014.04.018. Epub 2014 May 10. Eur Urol. 2014. PMID: 24813269 No abstract available.
• Re: Michael J. Morris, Daisy Huang, William K. Kelly, et al. Phase 1 trial of high-dose exogenous testosterone in patients with castration-resistant metastatic prostate. Eur Urol 2009;56:237-44.

  Drewa T, Chlosta P. Drewa T, et al. Eur Urol. 2010 Feb;57(2):e18-9; author reply e20. doi: 10.1016/j.eururo.2009.10.021. Epub 2009 Oct 20. Eur Urol. 2010. PMID: 19853990 No abstract available.
• Re: Ofer Yossepowitch, Anders Bjartell, James A. Eastham, et al. Positive surgical margins in radical prostatectomy: outlining the problem and its long-term consequences. Eur Urol 2009;55:87-99.

  Kynaston H, Parker CC, Sydes MR; RADICALS Trial Management Group. Kynaston H, et al. Eur Urol. 2009 Jun;55(6):e107. doi: 10.1016/j.eururo.2009.03.022. Epub 2009 Mar 13. Eur Urol. 2009. PMID: 19303202 No abstract available.
• Castration-resistant prostate cancer: from new pathophysiology to new treatment targets.

  Chi KN, Bjartell A, Dearnaley D, Saad F, Schröder FH, Sternberg C, Tombal B, Visakorpi T. Chi KN, et al. Eur Urol. 2009 Oct;56(4):594-605. doi: 10.1016/j.eururo.2009.06.027. Epub 2009 Jun 24. Eur Urol. 2009. PMID: 19560857 Review.
• Castration-resistant prostate cancer: targeted therapies.

  Leo S, Accettura C, Lorusso V. Leo S, et al. Chemotherapy. 2011;57(2):115-27. doi: 10.1159/000323581. Epub 2011 Mar 24. Chemotherapy. 2011. PMID: 21430379 Review.